-
-
-
-
-
-
-
Abbott trims 2026 profit forecast on Exact deal hit, shares fall
-
-
-
-
-
-
-
Exact Sciences shareholders approve $105 per share Abbott acquisition
-
-
-
-
-
-
-
Factbox-Major deals involving US drugmakers and biotechs over the past decade
-
-
-
-
-
-
-
Exact Sciences shares soar on report Abbott is nearing deal for the company
-
-
-
-
-
-
-
Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
-
-
-
-
-
-
-
Real-World Data Show Abbott's FreeStyle LibreĀ® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
-
-
-
-
-
-
-
Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
-
1,158,054 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

